According to Future Market Insights research, during the projected period, the global market is expected to grow at a CAGR of 7.2%. The market value is projected to increase from US$ 210.8 million in 2023 to US$ 421.4 million by 2033. The global market was valued at US$ 200.6 million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 6.3% in 2023.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 200.6 Million |
| Market Value 2023 | US$ 210.8 Million |
| Market Value 2033 | US$ 421.4 Million |
| CAGR 2023 to 2033 | 7.2% |
| Share of Top 5 Countries | 58.4% |
| Key Players | The key players in the Global Market Are Bio Rad Laboratories Inc.; ThermoFisher Scientific; Promega Corporation; Agilent Technologies; Bioneer Corporation; PerkinElmer Inc.; LGC Biosearch Technologies; Qiagen; General Biosystems; Takara Bio Inc.; Roche Life Science; GeneReach Biotechnology Corporation; Merck Millipore; BioFire Defense LLC; Akonni Biosystems; Inc. and Primerdesign Ltd. |
The process of RNA extraction, also known as RNA isolation, involves the separation of RNA from a cell. The utilization of this technique is advantageous in various applications such as gene expression analysis, pathogen identification, and classification. Due to its reliance on nucleic acid detection, this technique exhibits high levels of accuracy, reproducibility, and versatility.
The RNA of a living cell, regardless of its origin from an animal, plant, human, bacteria, or virus, is a valuable source of information regarding genetic material. As such, it is a crucial component of gene expression studies. The RNA lysis buffer is known to facilitate the lysis of the cell wall/membrane, whereas the utilization of organic solvents, such as phenol-chloroform, is commonly employed to effectuate the separation of RNA via centrifugation. The utilization of Phenol: Chloroform: Isoamyl alcohol in conjunction with centrifugation results in the formation of three distinct layers. These layers consist of the lower organic layer, the middle layer containing DNA and protein, and the upper aqueous layer containing RNA. The upper aqueous phase is carefully collected and subsequently subjected to precipitation, washing, and dissolution in RNase-free water.
RNA extraction plays an important role in cancer genetic research. It involves mutation analysis, comparative genomic hybridization, and microsatellite analysis. The rising incidence of cancer globally is resulting in the need for advanced RNA extraction kits, which in turn is expected to drive the market in the upcoming years.
Overall, the increasing adoption of the latest technologies such as mutation analysis and comparative genomic hybridization, the prevalence of cancer and the need for advanced genomic techniques, this factors will boost the market in the future.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of the global market grew at a CAGR of 8.6% between 2017 and 2022. The global market contributes 16.5% revenue share to the global extraction kit market valued at US$ 1.2 billion in 2022.
The accurate detection and monitoring of viral RNA are essential for understanding the prevalence, transmission, and control of viral diseases. Thus, RNA extraction kits play a critical role in diagnosing viral infections and conducting epidemiological surveillance.
Technological advancements, such as real-time polymerase chain reaction (PCR), real-time reverse transcription–polymerase chain (RT-PCR), and next-generation sequencing, have revolutionized molecular diagnostics. The increasing adoption of molecular diagnostic methods drives the demand for the global market.
During outbreaks and pandemics, the rapid and accurate detection of viral RNA is crucial for effective public health response. Extraction kits enable healthcare professionals and researchers to quickly identify the presence of viral pathogens, assess the extent of the outbreak, and implement appropriate control measures.
Viral RNA extraction kits are indispensable tools for researchers studying viral diseases. These kits enable the isolation and analysis of viral RNA, providing insights into viral pathogenesis, genetic diversity, and potential therapeutic targets. Advancements in research contribute to the development of new and improved extraction kits.
Considering this, FMI expects the global market to grow at a CAGR of 7.2% through 2023 to 2033.
In recent years, government agencies in the Asia-Pacific and the Middle East have easily encouraged manufacturers to drive industrial growth in the healthcare and bio-pharmacy industries. Key players can take advantage of regulatory scenarios to grow in the market.
For example, developing countries in the Asia-Pacific region, such as India, have lifted export restrictions on diagnostic kits and reagents, including equipment such as extraction kits and systems used to detect coronavirus infections.
In the COVID-19 pandemic, the life sciences division played a crucial role. Traditional competitors banded together to speed up research and develop the fastest new vaccines to combat the worldwide issue. The science, technology, and innovation (STI) response to COVID-19 is based on collaboration, with national and international collaborative platforms for technology, revolutionizing vaccine design and production.
Favourable government policies and rising research initiatives, collaboration activities amongst countries like the U.S. is supposed to set out promising open doors for key market players.
These factors are expected to provide growth opportunities to key players in the market over the forecast period.
Principal Consultant
The promotion of a mainstream biotech industry by several governments, akin to the extraction kit model, has encountered sluggish progress. It has been observed that the growth and progress of various regions are contingent upon the availability of proficient experts. A significant disparity has been observed by numerous organizations between proficient experts and the present labour pool. The dearth of seasoned professionals has impeded market expansion in numerous developing nations.
Changing regulatory dynamics is one of the restraining factors for the market such as each country's regulatory authorities and procedures may differ. While many follow the standards of large countries, such as the United States Food and Drug Administration (FDA), others have their approval timelines. In such circumstances, one provider is unable to introduce new or better items until all extraction kits have been validated.
Before beginning the distribution of their product or equipment, companies must wait for all regulatory approvals to be received. Validation is not necessary for US FDA-approved kits, however, it is essential for CE-IVD authorized/non-US FDA approved/indigenous kits, which require batch testing.
These factors are expected to hamper the revenue growth of the extraction kit market over the forecast period.
In the United States, the adoption of extraction kits is more due to extensive research and development activities in the fields of molecular biology.
The United States has a robust biotechnology and pharmaceutical industry that heavily relies on RNA extraction kits. Companies involved in drug discovery, diagnostic development, and therapeutic research require high-quality RNA samples for their research and development pipelines.
During the projected period, the U.S. market accounted for around 31.9% of the global market share in 2022.
Due to the advanced pharmaceutical and biotechnological industry in the U.S., there will be increasing demand for RNA extraction kits, which will drive the expansion of the market.
Germany dominated the European market and accounted for 7.5% of the global market share in the year 2022.
Germany has a strong research and development landscape, with renowned research institutions and universities engaged in virology research. Researchers studying viral diseases rely on extraction kits to isolate and analyze viral RNA for understanding the pathogenesis, developing vaccines, and designing therapeutic strategies.
Due to the strong research and development and German government support and funding, there will be demand for RNA extraction kits, which will drive the expansion of the market.
China dominated the East Asia market and accounted for around 49.6% of the regional market share in the year 2022.
China has the world's largest population, which increases the demand for the global market for diagnosing and monitoring viral infections. The country's focus on public health and disease control requires reliable tools for viral RNA detection and surveillance.
Global market demand is rising as more individuals become aware of the test and are thus more likely to adapt to the testing procedure.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The nasal washes and swab segment held significant chunk of about 37.9% in global market by the end of 2022.
Nasal washes and swabs allow for direct sampling of the respiratory tract, where many respiratory viruses, including SARS-CoV-2 (the virus causing COVID-19), primarily infect. These sample types can capture the virus directly from the nasal cavity, nasopharynx, or oropharynx, providing a representative sample of the viral load present in the respiratory system.
Non-invasive collection and high viral load in respiratory secretions are one of the reasons for the increasing adoption of nasal swabs.
Overall, nasal washes and the swab is used as sample type for RNA extraction due to their high specificity.
The disease diagnosis segment accounted for a revenue share of 37.1% in the global market at the end of 2022.
The utilization of viral RNA extraction kits is crucial in the identification of viral infections. It has been observed that various viruses, including but not limited to SARS-CoV-2 (COVID-19), influenza viruses, and respiratory syncytial virus (RSV), possess RNA as their genetic material.
By isolating and extracting viral RNA from patient samples, it becomes possible to detect the presence of the virus and diagnose the corresponding viral infection.
Overall, disease diagnosis offers monitoring of treatment efficiency, making it the most significant sample for this segment.
The diagnostic laboratories segment accounted for a revenue share of 30.1% in the global market at the end of 2022.
Diagnostic laboratories are essential for the global market as they ensure accurate diagnosis, maintain quality standards, validate tests, handle high testing volumes, provide expert interpretation, and contribute to collaborative networks for effective disease management.
Overall, diagnostic Laboratories offer convenient testing options, making them the dominant end user for this segment.
The viral RNA extraction kit market's major companies are concentrating on diversifying their product offerings to boost their market share and establish a presence in developing nations. Pricing strategies, market strategies, technology improvements, regulatory compliance, and acquisition and distribution agreements with other firms to extend their company are the main tactics used by manufacturers to acquire a competitive advantage in the market.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the global market space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD Million for Value, Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, BENELUX, Nordics, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Türkiye, South Africa, North Africa and GCC Countries |
| Key Segments Covered | Sample Type, Application, End User, Region |
| Key Companies Profiled |
Bio Rad Laboratories Inc.; ThermoFisher Scientific; Promega Corporation; Agilent Technologies; Bioneer Corporation; PerkinElmer Inc.; LGC Biosearch Technologies; Qiagen; General Biosystems; Takara Bio Inc.; Roche Life Science; GeneReach Biotechnology Corporation; Merck Millipore; BioFire Defense LLC; Akonni Biosystems, Inc.; Primerdesign Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The projected CAGR of the viral RNA extraction kit market by 2033 is 7.2%.
The projected market value by 2033 is US$ 421.4 million.
The market is estimated to secure a valuation of US$ 210.8 million in 2023.
The health and diagnostic industry is the leading consumer of the market.
The increasing prevalence of viral infections is the key opportunity in the kit market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Value Added Insights
4.1. Product Adoption Analysis
4.2. Technological Roadmap
4.3. Regulatory Scenario
4.4. Regional PESTLE Analysis
4.5. Porter’s Analysis
4.6. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure
5.1.2. Global Extraction Kits Market
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Increasing Treatment Seeking Rate
5.2.3. New Test Type Launches/Approvals
5.2.4. Increasing Incidence of Infectious diseases
5.2.5. Government Initiatives to Combat Cancer
5.2.6. Companies Increasingly Spending on R&D and Focus on Innovation
5.2.7. Collaborations and Agreements between Manufacturers
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Volume Analysis, 2017 to 2022
6.2. Current and Future Market Volume Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market – Pricing Assessment
7.1. Regional Pricing Analysis
7.2. Global Average Pricing Analysis Benchmark
7.3. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Sample Type, 2023 to 2033
9.3.1. Nasal Washes and Swab
9.3.2. Sputum
9.3.3. Saliva
9.3.4. Fecal & Stool
9.3.5. Urine
9.3.6. Blood
9.3.7. Tissues
9.3.8. Others
9.4. Market Attractiveness Analysis by Sample Type
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis by Application, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2023 to 2033
10.3.1. Disease Diagnosis
10.3.2. Drug Discovery
10.3.3. Cancer Research
10.3.4. cDNA Library
10.3.5. Others
10.4. Market Attractiveness Analysis by Application
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033
11.3.1. Hospitals
11.3.2. Academic & Research Institutes
11.3.3. Pharmaceutical & Biotechnology Companies
11.3.4. Clinical Research Organizations
11.3.5. Diagnostic Laboratories
11.3.6. Forensic Labs
11.3.7. Others
11.4. Market Attractiveness Analysis by End User
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis by Countries
13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
13.3.1. By Countries
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Sample Type
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Countries
13.4.2. By Sample Type
13.4.3. By Application
13.4.4. By End User
13.5. Drivers & Restraints Impact Analysis
13.6. Country-wise Analysis
13.6.1. U.S. Market Analysis
13.6.1.1. Introduction
13.6.1.2. Market Analysis and Forecast by Market Taxonomy
13.6.1.2.1. By Sample Type
13.6.1.2.2. By Application
13.6.1.2.3. By End User
13.6.2. Canada Market Analysis
13.6.2.1. Introduction
13.6.2.2. Market Analysis and Forecast by Market Taxonomy
13.6.2.2.1. By Sample Type
13.6.2.2.2. By Application
13.6.2.2.3. By End User
14. Latin America Global Viral Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
14.3.1. By Countries
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Sample Type
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Countries
14.4.2. By Sample Type
14.4.3. By Application
14.4.4. By End User
14.5. Drivers & Restraints Impact Analysis
14.6. Country-wise Analysis
14.6.1. Brazil Market Analysis
14.6.1.1. Introduction
14.6.1.2. Market Analysis and Forecast by Market Taxonomy
14.6.1.2.1. By Sample Type
14.6.1.2.2. By Application
14.6.1.2.3. By End User
14.6.2. Mexico Market Analysis
14.6.2.1. Introduction
14.6.2.2. Market Analysis and Forecast by Market Taxonomy
14.6.2.2.1. By Sample Type
14.6.2.2.2. By Application
14.6.2.2.3. By End User
14.6.3. Argentina Market Analysis
14.6.3.1. Introduction
14.6.3.2. Market Analysis and Forecast by Market Taxonomy
14.6.3.2.1. By Sample Type
14.6.3.2.2. By Application
14.6.3.2.3. By End User
15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.3.1. By Countries
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Sample Type
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Countries
15.4.2. By Sample Type
15.4.3. By Application
15.4.4. By End User
15.5. Drivers & Restraints Impact Analysis
15.6. Country-wise Analysis
15.6.1. Germany Market Analysis
15.6.1.1. Introduction
15.6.1.2. Market Analysis and Forecast by Market Taxonomy
15.6.1.2.1. By Sample Type
15.6.1.2.2. By Application
15.6.1.2.3. By End User
15.6.2. Italy Market Analysis
15.6.2.1. Introduction
15.6.2.2. Market Analysis and Forecast by Market Taxonomy
15.6.2.2.1. By Sample Type
15.6.2.2.2. By Application
15.6.2.2.3. By End User
15.6.3. France Market Analysis
15.6.3.1. Introduction
15.6.3.2. Market Analysis and Forecast by Market Taxonomy
15.6.3.2.1. By Sample Type
15.6.3.2.2. By Application
15.6.3.2.3. By End User
15.6.4. U.K. Market Analysis
15.6.4.1. Introduction
15.6.4.2. Market Analysis and Forecast by Market Taxonomy
15.6.4.2.1. By Sample Type
15.6.4.2.2. By Application
15.6.4.2.3. By End User
15.6.5. Spain Market Analysis
15.6.5.1. Introduction
15.6.5.2. Market Analysis and Forecast by Market Taxonomy
15.6.5.2.1. By Sample Type
15.6.5.2.2. By Application
15.6.5.2.3. By End User
15.6.6. BENELUX Market Analysis
15.6.6.1. Introduction
15.6.6.2. Market Analysis and Forecast by Market Taxonomy
15.6.6.2.1. By Sample Type
15.6.6.2.2. By Application
15.6.6.2.3. By End User
15.6.7. Russia Market Analysis
15.6.7.1. Introduction
15.6.7.2. Market Analysis and Forecast by Market Taxonomy
15.6.7.2.1. By Sample Type
15.6.7.2.2. By Application
15.6.7.2.3. By End User
16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Countries
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Sample Type
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Countries
16.4.2. By Sample Type
16.4.3. By Application
16.4.4. By End User
16.5. Drivers & Restraints Impact Analysis
16.6. Country-wise Analysis
16.6.1. India Market Analysis
16.6.1.1. Introduction
16.6.1.2. Market Analysis and Forecast by Market Taxonomy
16.6.1.2.1. By Sample Type
16.6.1.2.2. By Application
16.6.1.2.3. By End User
16.6.2. Indonesia Market Analysis
16.6.2.1. Introduction
16.6.2.2. Market Analysis and Forecast by Market Taxonomy
16.6.2.2.1. By Sample Type
16.6.2.2.2. By Application
16.6.2.2.3. By End User
16.6.3. Malaysia Market Analysis
16.6.3.1. Introduction
16.6.3.2. Market Analysis and Forecast by Market Taxonomy
16.6.3.2.1. By Sample Type
16.6.3.2.2. By Application
16.6.3.2.3. By End User
16.6.4. Thailand Market Analysis
16.6.4.1. Introduction
16.6.4.2. Market Analysis and Forecast by Market Taxonomy
16.6.4.2.1. By Sample Type
16.6.4.2.2. By Application
16.6.4.2.3. By End User
17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Countries
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Sample Type
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Countries
17.4.2. By Sample Type
17.4.3. By Application
17.4.4. By End User
17.5. Drivers & Restraints Impact Analysis
17.6. Country-wise Analysis
17.6.1. China Market Analysis
17.6.1.1. Introduction
17.6.1.2. Market Analysis and Forecast by Market Taxonomy
17.6.1.2.1. By Sample Type
17.6.1.2.2. By Application
17.6.1.2.3. By End User
17.6.2. Japan Market Analysis
17.6.2.1. Introduction
17.6.2.2. Market Analysis and Forecast by Market Taxonomy
17.6.2.2.1. By Sample Type
17.6.2.2.2. By Application
17.6.2.2.3. By End User
17.6.3. South Korea Market Analysis
17.6.3.1. Introduction
17.6.3.2. Market Analysis and Forecast by Market Taxonomy
17.6.3.2.1. By Sample Type
17.6.3.2.2. By Application
17.6.3.2.3. By End User
18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Countries
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Sample Type
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Countries
18.4.2. By Sample Type
18.4.3. By Application
18.4.4. By End User
18.5. Drivers & Restraints Impact Analysis
18.6. Country-wise Analysis
18.6.1. Australia Market Analysis
18.6.1.1. Introduction
18.6.1.2. Market Analysis and Forecast by Market Taxonomy
18.6.1.2.1. By Sample Type
18.6.1.2.2. By Application
18.6.1.2.3. By End User
18.6.2. New Zealand Market Analysis
18.6.2.1. Introduction
18.6.2.2. Market Analysis and Forecast by Market Taxonomy
18.6.2.2.1. By Sample Type
18.6.2.2.2. By Application
18.6.2.2.3. By End User
19. Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
19.3.1. By Countries
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. South Africa
19.3.1.4. Rest of MEA
19.3.2. By Sample Type
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Countries
19.4.2. By Sample Type
19.4.3. By Application
19.4.4. By End User
19.5. Drivers & Restraints Impact Analysis
19.6. Country-wise Analysis
19.6.1. GCC Countries Market Analysis
19.6.1.1. Introduction
19.6.1.2. Market Analysis and Forecast by Market Taxonomy
19.6.1.2.1. By Sample Type
19.6.1.2.2. By Application
19.6.1.2.3. By End User
19.6.2. Türkiye Market Analysis
19.6.2.1. Introduction
19.6.2.2. Market Analysis and Forecast by Market Taxonomy
19.6.2.2.1. By Sample Type
19.6.2.2.2. By Application
19.6.2.2.3. By End User
19.6.3. South Africa Market Analysis
19.6.3.1. Introduction
19.6.3.2. Market Analysis and Forecast by Market Taxonomy
19.6.3.2.1. By Sample Type
19.6.3.2.2. By Application
19.6.3.2.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players (%)
20.3. Market Concentration
21. Competition Analysis
21.1. Competition Dashboard
21.2. Key Development Analysis
21.3. Branding and Promotional Strategies, By key players
21.4. Competition Deep Dive
21.4.1. Bio-Rad Laboratories Inc.
21.4.1.1. Overview
21.4.1.2. Product Portfolio
21.4.1.3. Key Financials
21.4.1.4. SWOT Analysis
21.4.1.5. Key Developments
21.4.1.6. Sales Footprint
21.4.1.7. Strategy Overview
21.4.1.7.1. Marketing Strategy
21.4.1.7.2. Product Strategy
21.4.1.7.3. Channel Strategy
21.4.2. ThermoFisher Scientific
21.4.2.1. Overview
21.4.2.2. Product Portfolio
21.4.2.3. Key Financials
21.4.2.4. SWOT Analysis
21.4.2.5. Key Developments
21.4.2.6. Sales Footprint
21.4.2.7. Strategy Overview
21.4.2.7.1. Marketing Strategy
21.4.2.7.2. Product Strategy
21.4.2.7.3. Channel Strategy
21.4.3. Promega Corporation
21.4.3.1. Overview
21.4.3.2. Product Portfolio
21.4.3.3. Key Financials
21.4.3.4. SWOT Analysis
21.4.3.5. Key Developments
21.4.3.6. Sales Footprint
21.4.3.7. Strategy Overview
21.4.3.7.1. Marketing Strategy
21.4.3.7.2. Product Strategy
21.4.3.7.3. Channel Strategy
21.4.4. Agilent Technologies
21.4.4.1. Overview
21.4.4.2. Product Portfolio
21.4.4.3. Key Financials
21.4.4.4. SWOT Analysis
21.4.4.5. Key Developments
21.4.4.6. Sales Footprint
21.4.4.7. Strategy Overview
21.4.4.7.1. Marketing Strategy
21.4.4.7.2. Product Strategy
21.4.4.7.3. Channel Strategy
21.4.5. Bioneer Corporation
21.4.5.1. Overview
21.4.5.2. Product Portfolio
21.4.5.3. Key Financials
21.4.5.4. SWOT Analysis
21.4.5.5. Key Developments
21.4.5.6. Sales Footprint
21.4.5.7. Strategy Overview
21.4.5.7.1. Marketing Strategy
21.4.5.7.2. Product Strategy
21.4.5.7.3. Channel Strategy
21.4.6. PerkinElmer Inc.
21.4.6.1. Overview
21.4.6.2. Product Portfolio
21.4.6.3. Key Financials
21.4.6.4. SWOT Analysis
21.4.6.5. Key Developments
21.4.6.6. Sales Footprint
21.4.6.7. Strategy Overview
21.4.6.7.1. Marketing Strategy
21.4.6.7.2. Product Strategy
21.4.6.7.3. Channel Strategy
21.4.7. LGC Biosearch Technologies
21.4.7.1. Overview
21.4.7.2. Product Portfolio
21.4.7.3. Key Financials
21.4.7.4. SWOT Analysis
21.4.7.5. Key Developments
21.4.7.6. Sales Footprint
21.4.7.7. Strategy Overview
21.4.7.7.1. Marketing Strategy
21.4.7.7.2. Product Strategy
21.4.7.7.3. Channel Strategy
21.4.8. Qiagen
21.4.8.1. Overview
21.4.8.2. Product Portfolio
21.4.8.3. Key Financials
21.4.8.4. SWOT Analysis
21.4.8.5. Key Developments
21.4.8.6. Sales Footprint
21.4.8.7. Strategy Overview
21.4.8.7.1. Marketing Strategy
21.4.8.7.2. Product Strategy
21.4.8.7.3. Channel Strategy
21.4.9. General Biosystems
21.4.9.1. Overview
21.4.9.2. Product Portfolio
21.4.9.3. Key Financials
21.4.9.4. SWOT Analysis
21.4.9.5. Key Developments
21.4.9.6. Sales Footprint
21.4.9.7. Strategy Overview
21.4.9.7.1. Marketing Strategy
21.4.9.7.2. Product Strategy
21.4.9.7.3. Channel Strategy
21.4.10. Takara Bio Inc.
21.4.10.1. Overview
21.4.10.2. Product Portfolio
21.4.10.3. Key Financials
21.4.10.4. SWOT Analysis
21.4.10.5. Key Developments
21.4.10.6. Sales Footprint
21.4.10.7. Strategy Overview
21.4.10.7.1. Marketing Strategy
21.4.10.7.2. Product Strategy
21.4.10.7.3. Channel Strategy
21.4.11. Roche Life Science
21.4.11.1. Overview
21.4.11.2. Product Portfolio
21.4.11.3. Key Financials
21.4.11.4. SWOT Analysis
21.4.11.5. Key Developments
21.4.11.6. Sales Footprint
21.4.11.7. Strategy Overview
21.4.11.7.1. Marketing Strategy
21.4.11.7.2. Product Strategy
21.4.11.7.3. Channel Strategy
21.4.12. GeneReach Biotechnology Corporation
21.4.12.1. Overview
21.4.12.2. Product Portfolio
21.4.12.3. Key Financials
21.4.12.4. SWOT Analysis
21.4.12.5. Key Developments
21.4.12.6. Sales Footprint
21.4.12.7. Strategy Overview
21.4.12.7.1. Marketing Strategy
21.4.12.7.2. Product Strategy
21.4.12.7.3. Channel Strategy
21.4.13. Merck Millipore
21.4.13.1. Overview
21.4.13.2. Product Portfolio
21.4.13.3. Key Financials
21.4.13.4. SWOT Analysis
21.4.13.5. Key Developments
21.4.13.6. Sales Footprint
21.4.13.7. Strategy Overview
21.4.13.7.1. Marketing Strategy
21.4.13.7.2. Product Strategy
21.4.13.7.3. Channel Strategy
21.4.14. BioFire Defense LLC
21.4.14.1. Overview
21.4.14.2. Product Portfolio
21.4.14.3. Key Financials
21.4.14.4. SWOT Analysis
21.4.14.5. Key Developments
21.4.14.6. Sales Footprint
21.4.14.7. Strategy Overview
21.4.14.7.1. Marketing Strategy
21.4.14.7.2. Product Strategy
21.4.14.7.3. Channel Strategy
21.4.15. Akonni Biosystems, Inc.
21.4.15.1. Overview
21.4.15.2. Product Portfolio
21.4.15.3. Key Financials
21.4.15.4. SWOT Analysis
21.4.15.5. Key Developments
21.4.15.6. Sales Footprint
21.4.15.7. Strategy Overview
21.4.15.7.1. Marketing Strategy
21.4.15.7.2. Product Strategy
21.4.15.7.3. Channel Strategy
21.4.16. Primerdesign Ltd.
21.4.16.1. Overview
21.4.16.2. Product Portfolio
21.4.16.3. Key Financials
21.4.16.4. SWOT Analysis
21.4.16.5. Key Developments
21.4.16.6. Sales Footprint
21.4.16.7. Strategy Overview
21.4.16.7.1. Marketing Strategy
21.4.16.7.2. Product Strategy
21.4.16.7.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Viral RNA Extraction Kit Market
